Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.870
+0.170 (4.59%)
At close: Dec 5, 2025
Arctic Bioscience AS Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 2.49 | 3.28 | 79.6 | 144.15 | 227.36 | 12.6 | Upgrade
|
| Cash & Short-Term Investments | 2.49 | 3.28 | 79.6 | 144.15 | 227.36 | 12.6 | Upgrade
|
| Cash Growth | -87.44% | -95.88% | -44.78% | -36.60% | 1704.45% | -46.18% | Upgrade
|
| Accounts Receivable | 10.53 | 14.57 | 9.57 | 13.48 | 7.7 | 11.01 | Upgrade
|
| Other Receivables | 9.64 | 11.05 | 11.19 | 5.24 | 3.34 | 2.78 | Upgrade
|
| Receivables | 20.16 | 25.62 | 20.76 | 18.71 | 11.05 | 13.78 | Upgrade
|
| Inventory | 32.56 | 28.99 | 32.79 | 35.46 | 28.53 | 26.25 | Upgrade
|
| Total Current Assets | 55.22 | 57.89 | 133.15 | 198.33 | 266.93 | 52.63 | Upgrade
|
| Property, Plant & Equipment | 23.76 | 24.47 | 26.44 | 22.33 | 15.99 | 6.36 | Upgrade
|
| Goodwill | 1.63 | 1.93 | 2.53 | - | - | - | Upgrade
|
| Other Intangible Assets | 1.48 | 1.59 | 1.78 | 2.14 | 2.33 | 2.3 | Upgrade
|
| Long-Term Deferred Charges | 208.26 | 193.87 | 136.35 | 104.9 | 56.22 | 31.9 | Upgrade
|
| Other Long-Term Assets | - | 0 | - | -0 | - | - | Upgrade
|
| Total Assets | 290.35 | 279.74 | 300.25 | 327.7 | 341.47 | 93.2 | Upgrade
|
| Accounts Payable | 15.54 | 18.98 | 18.38 | 18.25 | 8.36 | 9.93 | Upgrade
|
| Accrued Expenses | 24.35 | 28.33 | 21.27 | 22.17 | 12.56 | 10.87 | Upgrade
|
| Short-Term Debt | 26.96 | 20.24 | - | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0 | 1.88 | Upgrade
|
| Other Current Liabilities | - | -0 | - | - | -0 | - | Upgrade
|
| Total Current Liabilities | 66.84 | 67.54 | 39.65 | 40.42 | 20.92 | 22.68 | Upgrade
|
| Long-Term Debt | 12.04 | - | - | - | - | 6.58 | Upgrade
|
| Long-Term Leases | 16.17 | 1.47 | 2.05 | - | - | - | Upgrade
|
| Total Liabilities | 95.05 | 69.01 | 41.69 | 40.42 | 20.92 | 29.26 | Upgrade
|
| Common Stock | 2.69 | 2.54 | 2.54 | 2.44 | 2.43 | 1.29 | Upgrade
|
| Additional Paid-In Capital | 192.61 | 208.19 | 256.02 | 284.84 | 318.12 | 40.01 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | - | 22.64 | Upgrade
|
| Shareholders' Equity | 195.3 | 210.73 | 258.56 | 287.28 | 320.55 | 63.94 | Upgrade
|
| Total Liabilities & Equity | 290.35 | 279.74 | 300.25 | 327.7 | 341.47 | 93.2 | Upgrade
|
| Total Debt | 55.16 | 21.71 | 2.05 | - | 0 | 8.46 | Upgrade
|
| Net Cash (Debt) | -52.67 | -18.43 | 77.55 | 144.15 | 227.36 | 4.14 | Upgrade
|
| Net Cash Growth | - | - | -46.20% | -36.60% | 5385.57% | -74.50% | Upgrade
|
| Net Cash Per Share | -2.02 | -0.73 | 3.05 | 5.89 | 9.34 | 0.30 | Upgrade
|
| Filing Date Shares Outstanding | 26.86 | 25.37 | 25.37 | 24.46 | 24.3 | 13.88 | Upgrade
|
| Total Common Shares Outstanding | 26.86 | 25.37 | 25.37 | 24.46 | 24.3 | 13.88 | Upgrade
|
| Working Capital | -11.63 | -9.65 | 93.51 | 157.9 | 246.01 | 29.95 | Upgrade
|
| Book Value Per Share | 7.27 | 8.31 | 10.19 | 11.75 | 13.19 | 4.61 | Upgrade
|
| Tangible Book Value | 192.19 | 207.21 | 254.25 | 285.14 | 318.23 | 61.63 | Upgrade
|
| Tangible Book Value Per Share | 7.16 | 8.17 | 10.02 | 11.66 | 13.10 | 4.44 | Upgrade
|
| Buildings | 15.75 | 15.56 | - | 20.38 | 14.17 | - | Upgrade
|
| Machinery | 17.19 | 17.26 | - | 5.17 | 4.08 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.